Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Jazz Pharmaceuticals Inc (JAZZ)  
$109.27 0.37 (0.34%) as of 4:30 Thu 4/18


Download
   
Exchange: Nasdaq National Market
Security Type: N/A
Shares Out: 61,150,000
Market Cap: 6.68(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $113.49 - $145.93
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  845
Guru Rank Value     : 2.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Jazz Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing medicines for patients with serious diseases with limited or no options. Co.'s primary marketed products are: Xyrem® (sodium oxybate) oral solution, for the treatment of both cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Xywav™ (calcium, magnesium, potassium, and sodium oxybates) oral solution, for the treatment of cataplexy or EDS in narcolepsy patients seven years of age and older; and Sunosi® (solriamfetol), to improve wakefulness in adult patients with EDS associated with narcolepsy or obstructive sleep apnea.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 101,621 101,621 101,621 113,621
Total Buy Value $9,993,082 $9,993,082 $9,993,082 $11,428,882
Total People Bought 1 1 1 2
Total Buy Transactions 2 2 2 3
Total Shares Sold 4,000 33,509 41,672 66,436
Total Sell Value $470,925 $4,604,514 $5,573,506 $8,769,463
Total People Sold 1 4 5 15
Total Sell Transactions 5 14 19 39
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 798
  Page 1 of 32  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cozadd Bruce C Chairman & CEO   •       •      –    2025-06-03 4 AS $110.00 $55,000 D/D (500) 437,973     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2025-06-02 4 AS $107.90 $53,950 D/D (500) 438,473     -
   Mulligan Seamus Director   –       •      –    2025-05-12 4 B $103.00 $166,962 I/I 1,621 101,621 2.1     -
   Mulligan Seamus Director   –       •      –    2025-05-09 4 B $98.10 $9,826,120 I/I 100,000 100,000 2.1     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2025-05-02 4 AS $120.00 $60,000 D/D (500) 438,807     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2025-05-01 4 AS $116.35 $116,350 D/D (1,000) 439,307     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2025-04-01 4 AS $123.75 $185,625 D/D (1,500) 440,307     -
   Iannone Robert EVP, Global Head of R&D & CMO   •       –      –    2025-03-10 4 S $138.41 $332,605 D/D (2,403) 79,621     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2025-03-10 4 S $137.81 $157,103 D/D (1,140) 7,012     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2025-03-07 4 D $138.23 $184,261 D/D (1,333) 8,152     -
   Henderson Mary Elizabeth SVP, Technical Operations   •       –      –    2025-03-07 4 D $138.23 $96,485 D/D (698) 23,077     -
   Iannone Robert EVP, Global Head of R&D & CMO   •       –      –    2025-03-07 4 AS $138.21 $981,298 D/D (7,080) 82,024     -
   Patil Neena M EVP & Chief Legal Officer   •       –      –    2025-03-05 4 D $138.95 $568,028 D/D (4,088) 47,526     -
   Gala Renee D President & COO   •       –      –    2025-03-05 4 D $138.95 $792,571 D/D (5,704) 88,895     -
   Pearce Samantha EVP, Chief Commercial Officer   •       –      –    2025-03-05 4 D $138.95 $264,700 D/D (1,905) 41,226     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2025-03-05 4 D $138.95 $3,091,776 D/D (22,251) 441,807     -
   Johnson Philip L EVP & Chief Financial Officer   •       –      –    2025-03-05 4 D $138.95 $159,654 D/D (1,149) 50,060     -
   Iannone Robert EVP, Global Head of R&D & CMO   •       –      –    2025-03-05 4 D $138.95 $727,959 D/D (5,239) 89,104     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2025-03-03 4 AS $144.25 $937,625 D/D (6,500) 464,058     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2025-02-28 4 S $143.30 $110,767 D/D (773) 9,485     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2025-02-27 4 A $0.00 $0 D/D 2,889 10,258     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2025-02-27 4 D $142.43 $123,629 D/D (868) 7,369     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2025-02-27 4 S $144.42 $695,075 D/D (4,813) 8,237     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2025-02-27 4 OE $113.10 $547,562 D/D 4,813 8,550     -
   Henderson Mary Elizabeth SVP, Technical Operations   •       –      –    2025-02-27 4 A $0.00 $0 D/D 9,244 23,775     -
  798 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 32
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us